[
  {
    "id": "workflow_001",
    "name": "ROPAD Parkinson's Patient Referral Triage",
    "description": "Triages potential patient referrals from the ROPAD genetics study and forwards them to the BIIB122/DNL151 study team and Biogen partner contacts.",
    "modified": "2024-05-20",
    "approval": "Yes",
    "actions": [
      {
        "actionNumber": 1,
        "action": "Acknowledge Referral Receipt",
        "input": "email",
        "output": "email",
        "description": "Send an automated acknowledgment to the ROPAD site confirming receipt of the referral."
      },
      {
        "actionNumber": 2,
        "action": "Forward to Study Team",
        "input": "email",
        "output": "email",
        "description": "Forward the de-identified patient information to the internal DNL151 team and Biogen contacts for review."
      }
    ]
  },
  {
    "id": "workflow_002",
    "name": "Initial SAE Triage for ALS Study (DNL343)",
    "description": "Receives SAE reports from clinical sites for the DNL343 study, acknowledges receipt, and forwards them to the internal pharmacovigilance team.",
    "modified": "2024-05-21",
    "approval": "No",
    "actions": [
      {
        "actionNumber": 1,
        "action": "Acknowledge Site Report",
        "input": "email",
        "output": "email",
        "description": "Send an automated confirmation to the reporting site that their SAE report has been received."
      },
      {
        "actionNumber": 2,
        "action": "Route to Pharmacovigilance",
        "input": "email",
        "output": "email",
        "description": "Forward the complete SAE report to the Denali PV intake group for processing and safety database entry."
      }
    ]
  },
  {
    "id": "workflow_003",
    "name": "Site Inquiry Routing",
    "description": "Monitors the clinical-trials@dnli.com inbox, categorizes incoming site inquiries, and routes them to the appropriate internal department.",
    "modified": "2024-05-15",
    "approval": "Yes",
    "actions": [
      {
        "actionNumber": 1,
        "action": "Categorize and Forward Inquiry",
        "input": "email",
        "output": "email",
        "description": "Scan email for keywords (e.g., 'protocol', 'payment', 'IRB') and forward to the correct internal team (Clinical Ops, Medical, Finance)."
      },
      {
        "actionNumber": 2,
        "action": "Log Inquiry in CTMS",
        "input": "email",
        "output": "CTMS",
        "description": "Create a record of the site communication and its routing in the Clinical Trial Management System."
      }
    ]
  },
  {
    "id": "workflow_004",
    "name": "Partner Milestone Notification (TAK-594/DNL593)",
    "description": "Automates the notification of key study milestones for the TAK-594/DNL593 trial to the Takeda joint project team.",
    "modified": "2024-05-18",
    "approval": "No",
    "actions": [
      {
        "actionNumber": 1,
        "action": "Draft and Send Milestone Update",
        "input": "email",
        "output": "email",
        "description": "Upon receiving an internal trigger, format and send a standardized milestone update email to the Takeda collaboration manager."
      }
    ]
  },
  {
    "id": "workflow_005",
    "name": "Pediatric Consent Form Distribution (DNL126)",
    "description": "Handles requests from sites for the latest approved pediatric consent and assent forms for the DNL126 (MPS IIIA) study.",
    "modified": "2024-05-19",
    "approval": "No",
    "actions": [
      {
        "actionNumber": 1,
        "action": "Fulfill Form Request",
        "input": "email",
        "output": "email",
        "description": "Reply to the site's request with a secure link to the current, IRB-approved consent/assent form package stored in the eTMF."
      }
    ]
  }
]